MA43834A - Combinaison pour traiter la douleur - Google Patents
Combinaison pour traiter la douleurInfo
- Publication number
- MA43834A MA43834A MA043834A MA43834A MA43834A MA 43834 A MA43834 A MA 43834A MA 043834 A MA043834 A MA 043834A MA 43834 A MA43834 A MA 43834A MA 43834 A MA43834 A MA 43834A
- Authority
- MA
- Morocco
- Prior art keywords
- combination
- treat pain
- pain
- treat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662311781P | 2016-03-22 | 2016-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43834A true MA43834A (fr) | 2018-11-28 |
Family
ID=59900848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043834A MA43834A (fr) | 2016-03-22 | 2017-03-22 | Combinaison pour traiter la douleur |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11529340B2 (fr) |
| EP (1) | EP3432884A4 (fr) |
| JP (1) | JP2019509321A (fr) |
| AU (1) | AU2017238208B2 (fr) |
| CA (1) | CA3018750A1 (fr) |
| MA (1) | MA43834A (fr) |
| WO (1) | WO2017165558A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3873447A1 (fr) * | 2018-10-29 | 2021-09-08 | Hadasit Medical Research Services and Development Ltd. | Combinaison de modulateurs du récepteur m-opioïde (mor) à des fins de prévention et de traitement de la douleur, de la suicidalité et de troubles mentaux |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4816586A (en) | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| ES2121988T3 (es) | 1992-01-23 | 1998-12-16 | Toray Industries | Derivado de morfinano y uso medicinal. |
| KR100341950B1 (ko) | 1993-07-19 | 2002-11-29 | 도레이 가부시끼가이샤 | 뇌세포보호제 |
| AU686203B2 (en) | 1993-07-23 | 1998-02-05 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
| SE9401727D0 (sv) | 1994-05-18 | 1994-05-18 | Astra Ab | New compounds I |
| US6609682B2 (en) | 2001-07-19 | 2003-08-26 | Burl A. Rogers | Airplane landing gear suspension and shock-absorbing device |
| US7202259B2 (en) | 2002-11-18 | 2007-04-10 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
| CA2720312A1 (fr) | 2004-01-30 | 2005-08-18 | Euro-Celtique S.A. | Procedes d'elaboration de composes de 4-tetrazolyl-4-phenylpiperidine |
| JP5266492B2 (ja) | 2004-05-28 | 2013-08-21 | ヒューマン バイオモレキュラル リサーチ インスティテュート | 代謝安定性鎮痛薬、疼痛薬物療法及び他の物質の合成 |
| CA2593165A1 (fr) * | 2005-01-05 | 2006-07-13 | Regents Of The University Of Minnesota | Conjugues analgesiques |
| EP1888568A4 (fr) * | 2005-05-18 | 2009-08-12 | Neuraxon Inc | Composes de benzimidazole substitues a action a la fois inhibitrice de nos et agoniste opioide mu |
| WO2007035823A2 (fr) | 2005-09-20 | 2007-03-29 | Molecular Neuroimaging, Llc | Antagonistes partiels de mglur5 et leurs méthodes d'utilisation |
| US8461171B2 (en) | 2010-02-09 | 2013-06-11 | QRxPharma Ltd. | Hybrid opioid compounds and compositions |
| US10130674B2 (en) | 2010-02-09 | 2018-11-20 | Creative Bio-Peptides | Modified peptide that reduces pain in peripheral neuropathy |
| WO2014124317A1 (fr) | 2013-02-08 | 2014-08-14 | Regents Of The University Of Minnesota | Conjugués analgésiques |
| US10464941B2 (en) | 2015-02-24 | 2019-11-05 | Regents Of The University Of Minnesota | Therapeutic compounds |
-
2017
- 2017-03-22 MA MA043834A patent/MA43834A/fr unknown
- 2017-03-22 WO PCT/US2017/023647 patent/WO2017165558A1/fr not_active Ceased
- 2017-03-22 US US16/088,000 patent/US11529340B2/en active Active
- 2017-03-22 JP JP2018549940A patent/JP2019509321A/ja not_active Ceased
- 2017-03-22 EP EP17771090.2A patent/EP3432884A4/fr not_active Withdrawn
- 2017-03-22 CA CA3018750A patent/CA3018750A1/fr not_active Abandoned
- 2017-03-22 AU AU2017238208A patent/AU2017238208B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017238208B2 (en) | 2022-01-06 |
| WO2017165558A1 (fr) | 2017-09-28 |
| US11529340B2 (en) | 2022-12-20 |
| JP2019509321A (ja) | 2019-04-04 |
| AU2017238208A1 (en) | 2018-11-01 |
| US20200289489A1 (en) | 2020-09-17 |
| CA3018750A1 (fr) | 2017-09-28 |
| EP3432884A4 (fr) | 2019-11-20 |
| EP3432884A1 (fr) | 2019-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271085A (en) | Bacteria for the treatment of disorders | |
| EP3463464A4 (fr) | Traitement d'association | |
| IL263680A (en) | Combination therapies | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| EP3466435C0 (fr) | Agent améliorant la fonction cérébrale | |
| EP2968010A4 (fr) | Stimulation auditive-somatosensorielle personnalisée pour traiter un acouphène | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| SI3518783T1 (sl) | Naprava za zmanjševanje tkiva | |
| EP3245009C0 (fr) | Applicateur antiseptique | |
| EP3564335A4 (fr) | Agent de traitement de surface | |
| EP3500242A4 (fr) | Forme posologique fibreuse | |
| IL256206A (en) | Mct4 inhibitors for treating disease | |
| EP3378606A4 (fr) | Combinaison d'assistance | |
| SI4119569T1 (sl) | Konjugirane protismiselne spojine za uporabo v terapiji | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| EP3307268A4 (fr) | Phenyl-oxazolidinones substituées pour la thérapie antimicrobienne | |
| DK3408265T3 (da) | Terapeutiske forbindelser | |
| IL262851A (en) | Combination prime: boost therapy | |
| BR112017014839A2 (pt) | novos microbicidas | |
| EP3630331C0 (fr) | Traitement de fluide | |
| DK3302478T3 (da) | Pac-1 kombinations behandling | |
| MA46999A (fr) | Oligonucléotides modifiés pour traiter la polykystose rénale | |
| EP3554616C0 (fr) | Applicateur antiseptique | |
| DK3551166T3 (da) | Topisk phenytoin til anvendelse i behandling af periferisk neuropatisk smerte |